Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
复制标题

DOI:
10.1073/pnas.1318306111
复制
发表时间:
2014-02-18
影响因子:
11.1
通讯作者:
Cookson, Mark R.
Cookson, Mark R.
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Beilina, Alexandria;Rudenko, Iakov N.;Cookson, Mark R.

文献摘要

被引文献

相似文献

富含亮氨酸重复序列激酶2(LRRK 2)的突变导致遗传性帕金森病(PD),LRRK 2周围的常见变异是散发性PD的风险因素。使用蛋白质-蛋白质相互作用阵列,我们确定BCL 2相关的athanogene 5,Rab 7 L1(RAB 7,成员RAS癌基因家族样1),和细胞周期蛋白G相关激酶作为LRRK 2的结合伴侣。后两个基因是通过全基因组关联研究确定的散发性PD风险的候选基因。这些蛋白质形成复合物,其促进高尔基体衍生的囊泡通过体外和体内的自噬-溶酶体系统的清除。我们认为三种不同的PD基因具有共同的生物学功能。更一般地说,来自多个无偏筛选的数据整合可以提供对人类疾病机制的洞察。
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause inherited Parkinson disease (PD), and common variants around LRRK2 are a risk factor for sporadic PD. Using protein-protein interaction arrays, we identified BCL2-associated athanogene 5, Rab7L1 (RAB7, member RAS oncogene family-like 1), and Cyclin-G-associated kinase as binding partners of LRRK2. The latter two genes are candidate genes for risk for sporadic PD identified by genome-wide association studies. These proteins form a complex that promotes clearance of Golgi-derived vesicles through the autophagy-lysosome system both in vitro and in vivo. We propose that three different genes for PD have a common biological function. More generally, data integration from multiple unbiased screens can provide insight into human disease mechanisms.